SCHEMBL4067269

SCHEMBL4067269

COC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.59
DPP8 Q6V1X1 1/20 0.59
DPP9 Q86TI2 1/20 0.59
DPP7 Q9UHL4 1/20 0.59
PEPD P12955 7/20 0.56
XPNPEP1 Q9NQW7 3/20 0.53
POLB P06746 1/20 0.46
FKBP1A P62942 1/20 0.44
MMP3 P08254 1/20 0.43
ACE P12821 4/20 0.43
REN P00797 2/20 0.43
KDM4E B2RXH2 1/20 0.43
F2 P00734 1/20 0.43
LMNA P02545 1/20 0.43
LTA4H P09960 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
PTGS1 P23219 1/20 0.43
HTR2A P28223 1/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403908 1.00 DPP4 (0.59) DPP4DPP8DPP9DPP7PEPD
SCHEMBL4067266 1.00 DPP4 (0.59) DPP4DPP8DPP9DPP7PEPD
Hydrochloric Acid SCHEMBL7350211 0.99 DPP4 (0.58) DPP4DPP8DPP9DPP7PEPD
Hydrochloric Acid SCHEMBL7350214 0.99 DPP4 (0.58) DPP4DPP8DPP9DPP7PEPD
SCHEMBL29880455 0.86 PEPD (0.56) DPP4DPP8DPP9DPP7PEPD
SCHEMBL12191496 0.86 PEPD (0.52) PEPDXPNPEP1POLBFKBP1AMMP3
SCHEMBL15223625 0.86 PEPD (0.52) PEPDXPNPEP1POLBFKBP1AMMP3
SCHEMBL4411036 0.84 DPP4 (0.63) DPP4DPP8DPP9DPP7PEPD
SCHEMBL3052901 0.84 DPP4 (0.63) DPP4DPP8DPP9DPP7PEPD
SCHEMBL10056816 0.84 DPP4 (0.63) DPP4DPP8DPP9DPP7PEPD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613338-A4 TAMANDARIN ANALOGS AND FRAGMENTS THEREOF AND METHODS OF MAKING AND USING JOULLIE MADELEINE M (US) 2009-06-24 EP disclosed
EP-1613338-A2 TAMANDARIN ANALOGS AND FRAGMENTS THEREOF AND METHODS OF MAKING AND USING Joullie, Madeleine M. (US) 2006-01-11 EP disclosed
WO-2004084812-A2 TAMANDARIN ANALOGS AND FRAGMENTS THEREOF AND METHODS OF MAKING AND USING JOULLIE MADELEINE M (US) 2004-10-07 WO disclosed
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
WO-2001090095-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2001-11-29 WO disclosed
CN-1291993-A Thiadiazole compounds useful as cysteine activity dependent enzyme inhibitors APOTEX INC (CA) 2001-04-18 CN disclosed
US-6162791-A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes APOTEX INC. (CA) 2000-12-19 US disclosed
EP-1058690-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2000-12-13 EP disclosed
WO-1999045027-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 1999-09-10 WO disclosed
US-4382889-A Epoxysuccinic acid derivatives TAISHO PHARMACEUTICAL CO., LTD. (JP) 1983-05-10 US disclosed
US-4333879-A CALCIUM-ACTIVATED NEUTRAL THIOLPROTEASE INHIBITOR USED IN THE TREATMENT OF MUSCULAR DYSTROPHY TAISHO PHARMACEUTICAL CO., LTD. (JP) 1982-06-08 US disclosed